ONCOLOGY

The screening uptake rate in 2018-2019 was 73.1 per cent.

The most common HPV-attributable cancers reported during the study period were cervical and oropharyngeal.

No benefit for adding NACT to chemoradiation in locally advanced disease.

Distress within 1 year before or after cancer diagnosis increases mortality.

Objective response rate was 88% in advanced/recurrent disease.

Recurrence risk also doubled vs open radical hysterectomy.

Estimates based on a modelling by the University of Warwick.

Bevacizumab-bvzr could offer a cheaper alternative to the reference product.

The meta-analysis shows greater and faster impact and herd effects in countries with both multi-cohort and high vaccination coverage.

There is a misbelief that lesbian, gay and bisexual women are not at risk of cervical cancer.

HPV vaccination, testing best for preventing cervical cancer.

Findings from ACTLACC trial.

Platinum-based doublet therapy was less tolerable.

Similar local disease control, cancer-specific survival vs LDR brachytherapy.